Summary
The pharmacokinetics and bioavailability of cimetidine after 200mg given intravenously and orally was studied in 6 gastric and 6 duodenal ulcer patients aged between 28 and 64 years. There were no differences in any of the pharmacokinetic parameters between the two ulcer groups, but there was considerable variation which was mainly age-related.
Bioavailability was not complete, but was about 60% based on the plasma concentration data. The volume of distribution at steady-state was about 80% of body weight, and the plasma clearance value of 495ml/min was mainly due to renal clearance (293ml/min). The elimination half-life was approximately 2 hours. These pharmacokinetic parameters together with the percentage of dose excreted unchanged in urine following intravenous administration were all highly age correlated; all decreasing with age except the elimination half-life which increased with age.
Of clinical importance is the finding that the time for which the plasma concentration exceeded 0.5μg/ml following oral administration was also highly age-dependent, increasing by more than 2-fold in the elderly (53 to 64y) compared with the younger (28 to 45y) patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bodemar, G.; Norlander, B.; Fransson, L. and Walan, A.: The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine — studies in patients with peptic ulcer disease. British Journal of Clinical Pharmacology 7: 23–31 (1979).
Boxenbaum, H.G.; Riegelman, S. and Elashoff, R.M.: Statistical estimations in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 2: 123–148 (1974).
Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Cimetidine: A review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs 15: 93–131 (1978).
Burland, W.L.; Duncan, W.A.M.; Hesselbo, T.; Mills, J.G.; Sharpe, P.C.; Haggie, S.J. and Wyllie, J.H.: Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. British Journal of Clinical Pharmacology 2: 481–486 (1975).
Crooks, J.; O’Malley, K. and Stevenson, I.H.: Pharmacokinetics in the elderly. Clinical Pharmacokinetics 1: 280–296 (1976).
Delaney, J.C. and Ravey, M.: Cimetidine and mental confusion. Lancet 2: 512 (1977).
Finkelstein, W. and Isselbacher, K.J.: Drug therapy: Cimetidine. New England Journal of Medicine 299: 992–996 (1978).
Flind, A.C. and Rowley-Jones, D.: Mental confusion and cimetidine. Lancet 1: 379 (1979).
Gibaldi, M. and Perrier, D.: Pharmacokinetics, p. 129–174 (Marcel Dekker, New York 1975).
Goldstein, A.: Biostatistics: An introductory text, p. 34–92 (Macmillan, New York 1967).
Griffiths, R.; Lee, R.M. and Tayior, D.C.: Kinetics of cimetidine in man and experimental animals; in Burland and Simkins (Eds) Cimetidine, Proceedings of the Second International Symposium on Histamine H2-receptor Antagonists, p. 38–51 (Excerpta Medica, Amsterdam 1977).
Gugler, R. and Somogyi, A.: Reduced cimetidine clearance with age. New England Journal of Medicine 301: 435 (1979).
Randolph, W.C.; Osborne, V.L.; Walkenstein, S.S. and Intoccia, A.P.: High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine. Journal of Pharmaceutical Sciences 66: 1148–1150 (1977).
Schentag, J.J.; Cerra, F.B.; Calleri, G.; DeGiopper, E.; Rose, J.Q. and Bernhard, H.: Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet 1: 177–181 (1979).
Sedman, A.J. and Wagner, J.G.: AUTOAN — a decision-making pharmacokinetic computer program (Publication Distribution Service, Ann Arbor 1974).
Siersbaek-Nielsen, K.; Hansen, J.M.; Kampmann, J. and Kristensen, M.: Rapid evaluation of creatinine clearance. Lancet 1: 1133–1134 (1971).
Taylor, D.C.; Cresswell, P.R. and Bartlett, D.C.: The metabolism and elimination of cimetidine, a histamine H2-receptor antagonist, in the rat, dog and man. Drug Metabolism and Disposition 6: 21–30 (1978).
Triggs, E.J. and Nation, R.L.: Pharmacokinetics in the aged: A review. Journal of Pharmacokinetics and Biopharmaceutics 3: 387–418 (1975).
Wagner, J.G.: Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of the polyexponential equations which have been fitted to the data. Journal of Pharmacokinetics and Biopharmaceutics 4: 443–467 (1976).
Walkenstein, S.S.; Dubb, J.W.; Randolph, W.C.; Westlake, W.J.; State, R.M. and Intoccia, A.P.: Bioavailability of cimetidine in man. Gastroenterology 74: 360–365 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Somogyi, A., Rohner, HG. & Gugler, R. Pharmacokinetics and Bioavailability of Cimetidine in Gastric and Duodenal Ulcer Patients. Clin Pharmacokinet 5, 84–94 (1980). https://doi.org/10.2165/00003088-198005010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198005010-00003